SY46 - Adrenal Insufficiency: From Molecular Mechanisms to Precision Management and Future Therapies

Monday, June 15, 2026

10:30 AM - 12:00 PM CT

Location: Room W187

Symposium Chair(s)

Aled Rees, MD,PhD (he/him/his)

Doctor
Cardiff University
Cardiff, Wales, United Kingdom

Disclosure(s): Diurnal Ltd: Advisory Board (); Immedica Pharma AB: Honorarium Recipient (); Neurocrine Biosciences: Advisory Board (), Contracted Research (Principal Investigators must provide information, even if received by the institution) (), Honorarium Recipient (); Recordati Rare Disease: Advisory Board ()
Wiebke Arlt, MD DSc FRCP FMedSci

MRC Laboratory of Medical Sciences (LMS)
London, United Kingdom

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Aled Rees, MD,PhD: Diurnal Ltd: Advisory Board (); Immedica Pharma AB: Honorarium Recipient (); Neurocrine Biosciences: Advisory Board (), Contracted Research (Principal Investigators must provide information, even if received by the institution) (), Honorarium Recipient (); Recordati Rare Disease: Advisory Board ()

Wiebke Arlt, MD DSc FRCP FMedSci: No financial relationships to disclose

Christa Flueck, MD: No financial relationships to disclose

Presentations:

10:30 AM - 10:52 AM CT

Emerging Therapies: Gene Therapy Approaches for Adrenal Insufficiency
Symposium Speaker: Lara E. Graves, BVSc MBBS PhD FRACP (she/her/hers) – The Children's Hospital at Westmead
10:52 AM - 11:14 AM CT

Novel rare genetic etiologies of primary adrenal insufficiency in children.
Symposium Speaker: Tulay Guran – Marmara University
11:14 AM - 11:36 AM CT

New Paradigms for Glucocorticoid Therapy in Patients with Adrenal Insufficiency
Symposium Speaker: Eystein Husebye
11:36 AM - 11:58 AM CT

Adrenal Crisis and Mortality in Adrenal Insufficiency
Symposium Speaker: Chiara Sabbadin, MD, PhD (she/her/hers) – University Hospital of Padua